影像组学预测肺癌机器人立体定向放疗后放射性肺损伤与肿瘤结局:两家独立机构结果
研究基于两家机构接受机器人立体定向体部放疗的早期非小细胞肺癌患者计划CT,构建并验证影像组学模型预测局部肺纤维化与肿瘤结局。肿瘤结局模型在训练集表现良好但无法泛化至测试集,而局部肺纤维化模型在两机构均具预测价值。
要点
- 影像组学模型预测局部肺纤维化在训练集和测试集均有效。
- 肿瘤结局模型在训练集表现好但未能泛化至测试集。
- 最佳肺纤维化模型结合4个临床/剂量学变量与7个影像组学特征。
核心结论
- 精心设计的影像组学模型可跨机构预测早期肺癌SBRT后局部肺纤维化,但预测肿瘤结局的模型泛化困难。
研究设计与样本
- 训练队列为科隆大学医院110例原发不可手术I/IIa期NSCLC接受机器人SBRT的患者,测试队列为德国北部放射外科中心71例可比患者。
- 从勾画的GTV提取199个符合IBSI标准的不相关影像组学特征,构建预测局部肺纤维化、局部肿瘤控制、无病生存和总生存的正则化模型。
主要发现
- 两队列肿瘤结局无显著差异:36个月OS 56% vs. 43%(p=0.065),中位DFS 25 vs. 23个月(p=0.43),36个月LC 90% vs. 93%(p=0.197)。
- 局部肺纤维化发生率33% vs. 35%(p=0.75),所有事件均在36个月内观察到。
- 训练队列中影像组学模型可预测OS、DFS和LC(一致性指数0.77-0.99,p<0.005),但无法泛化至测试队列。
- 肺纤维化模型在训练集(一致性指数0.71-0.79,p<0.005)和测试集(一致性指数0.59-0.66,p<0.05)均有预测性。
- 最佳模型包含4个临床/剂量学变量(GTV-Dmean、PTV-D95%、Lung-D1ml、年龄)和7个影像组学特征(一致性指数0.66,p<0.03)。
关键数值与推荐
- 影像组学特征提取遵循IBSI标准,共199个不相关特征。
- 肺纤维化最佳模型一致性指数0.66(p<0.03),含4个临床/剂量学变量与7个影像组学特征。
临床怎么用
- 影像组学模型可用于跨机构预测早期肺癌机器人SBRT后局部肺纤维化,辅助毒性风险分层。
- 肿瘤结局预测模型暂不宜直接跨机构推广,需进一步外部验证。
局限性
- 肿瘤结局影像组学模型无法泛化至测试队列,提示外部验证仍具挑战。
- 局部肺纤维化模型在测试集的一致性指数中等(0.59-0.66)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To generate and validate state-of-the-art radiomics models for prediction of radiation-induced lung injury and oncologic outcome in non-small cell lung cancer (NSCLC) patients treated with robotic stereotactic body radiation therapy (SBRT). METHODS: Radiomics models were generated from the planning CT images of 110 patients with primary, inoperable stage I/IIa NSCLC who were treated with robotic SBRT using a risk-adapted fractionation scheme at the University Hospital Cologne (training cohort). In total, 199 uncorrelated radiomic features fulfilling the standards of the Image Biomarker Standardization Initiative (IBSI) were extracted from the outlined gross tumor volume (GTV). Regularized models (Coxnet and Gradient Boost) for the development of local lung fibrosis (LF), local tumor control (LC), disease-free survival (DFS) and overall survival (OS) were built from either clinical/ dosimetric variables, radiomics features or a combination thereof and validated in a comparable cohort of 71 patients treated by robotic SBRT at the Radiosurgery Center in Northern Germany (test cohort). RESULTS: Oncologic outcome did not differ significantly between the two cohorts (OS at 36 months 56% vs. 43%, p = 0.065; median DFS 25 months vs. 23 months, p = 0.43; LC at 36 months 90% vs. 93%, p = 0.197). Local lung fibrosis developed in 33% vs. 35% of the patients (p = 0.75), all events were observed within 36 months. In the training cohort, radiomics models were able to predict OS, DFS and LC (concordance index 0.77-0.99, p < 0.005), but failed to generalize to the test cohort. In opposite, models for the development of lung fibrosis could be generated from both clinical/dosimetric factors and radiomic features or combinations thereof, which were both predictive in the training set (concordance index 0.71- 0.79, p < 0.005) and in the test set (concordance index 0.59-0.66, p < 0.05). The best performing model included 4 clinical/dosimetric variables (GTV-Dmean, PTV-D95%, Lung-D1ml, age) and 7 radiomic features (concordance index 0.66, p < 0.03). CONCLUSION: Despite the obvious difficulties in generalizing predictive models for oncologic outcome and toxicity, this analysis shows that carefully designed radiomics models for prediction of local lung fibrosis after SBRT of early stage lung cancer perform well across different institutions.
引用
- Bousabarah K, Blanck O, Temming S, et al. Radiomics for prediction of radiation-induced lung injury and oncologic outcome after robotic stereotactic body radiotherapy of lung cancer: results from two independent institutions. Radiat Oncol. 2021. PMID: 33863358. doi:10.1186/s13014-021-01805-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。